A method of making a vaccine using animal derived component free (ADCF) cell culture technology, including the steps of attaching ADCF-adapted cells to a microcarrier including an attachment mechanism for attaching filipodia of the cells, the microcarrier being in a culture, growing the cells in ADCF maintenance media, infecting the cells with vaccine media, producing virus within the cells, and harvesting the virus. A vaccine produced by the above method in a pharmaceutically acceptable carrier. A vaccine production structure of ADCF-adapted cells removably attached to microcarrier beads including an attachment mechanism for attaching filipodia of the cells.

 
Web www.patentalert.com

< Pharmaceutical formulations for intranasal administration of protein comprising a chitosan or a derivative thereof

> Methods and compositions for generating bioactive assemblies of increased complexity and uses

> Human antibodies to human delta like ligand 4

~ 00519